Tiina Annamaria Salminen

Title: Tiina Annamaria Salminen: Innovator in Therapeutic Compounds

Introduction

Tiina Annamaria Salminen is a notable inventor based in Koski, Finland. She has made significant contributions to the field of therapeutic compounds, holding three patents that reflect her innovative spirit and dedication to advancing medical science.

Latest Patents

Her latest patents include "Compounds and their use in therapy," which focuses on thiophenepyrimidinone compounds. These compounds are particularly relevant for the treatment and prevention of steroid hormone-dependent diseases or disorders, specifically those requiring the inhibition of 17β-hydroxysteroid dehydrogenase enzymes. Another significant patent is "Crystalline VAP-1 and uses thereof," which pertains to crystalline vascular adhesion protein-1 (VAP-1). This invention emphasizes methods for utilizing structural information of crystalline human VAP-1 for ligand and inhibitor identification, design, and production, along with screening assays for detection.

Career Highlights

Throughout her career, Tiina has worked with prominent companies such as Solvay Pharmaceuticals B.V. and Solvay Pharmaceuticals GmbH. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the pharmaceutical industry.

Collaborations

Tiina has collaborated with notable colleagues, including Mark Stuart Johnson and Leena Hirvelae. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Tiina Annamaria Salminen is a distinguished inventor whose work in therapeutic compounds has the potential to impact the treatment of various diseases. Her patents and collaborations highlight her commitment to innovation in the medical field.